Bulk Inquiry
CK 1827452
- Omecamtiv Mecarbil - CK-452
- Soluble in DMSO
- MF: C20H24FN5O3
- MW: 401.43
Description
Selective cardiac specific myosin activator; clinically tested for its role in the treatment of left ventricular systolic heart failure.
KEYWORS: Omecamtiv Mecarbil | supplier | Myosin activator | CK 1827452 | CK-452 | CK1827452 | CAS [873697-71-3] | ATP | ATPase (cardiac specific myosin) | Activator | left ventricular systolic | heart failure | LVSHF
More Information
| Parent CAS No. | 873697-71-3 |
|---|---|
| Chemical Name | methyl 4-(2-fluoro-3-(3-(6-methylpyridin-3-yl)ureido)benzyl)piperazine-1-carboxylate |
| SMILES | C1(C)C=CC(NC(=O)NC2C=CC=C(CN3CCN(C(=O)OC)CC3)C=2F)=CN=1 |
| MFCD | N.A. |
| InChi | InChI=1S/C20H24FN5O3/c1-14-6-7-16(12-22-14)23-19(27)24-17-5-3-4-15(18(17)21)13-25-8-10-26(11-9-25)20(28)29-2/h3-7,12H,8-11,13H2,1-2H3,(H2,23,24,27) |
| InChiKey | RFUBTTPMWSKEIW-UHFFFAOYSA-N |
| CID | 11689883 |
| Short Description | Myosin activator |
References
- F Malik et al. The Selective Cardiac Myosin Activator, CK-1827452, a Calcium-Independent Inotrope, Increases Left Ventricular Systolic Function by Increasing Ejection Time Rather than the Velocity of Contraction. Circulation 2006, 114, 441.
- JR Teerlink. A novel approach to improve cardiac performance: cardiac myosin activators. Heart Fail Rev. 2009, 14(4), 289–298.
- RJ Solaro. CK-1827452, a sarcomere-directed cardiac myosin activator for acute and chronic heart disease. IDrugs. 2009 Apr;12(4):243-51.
Related Products
| AXON ID | NAME | FROM PRICE |
|---|---|---|
| 1695 | Digoxigenin bisdigitoxoside |
From $198.00 |
| 1826 | DBeQ |
From $99.00 |
| 1971 | TAK 438 |
From $159.50 |
| 2407 | BTB 1 |
From $77.00 |
| 2565 | N106 |
From $104.50 |
| 2663 | Rbin-1 |
From $137.50 |
| 2683 | MYK-461 |
From $132.00 |
| 2712 | Rbin-2 |
From $104.50 |
| 2718 | (±)-Blebbistatin |
From $104.50 |
| 3074 | (-)-Blebbistatin |
From $99.00 |
| 3144 | (+)-Blebbistatin |
From $99.00 |
| 4000 | Aficamten |
From $176.00 |
